Background Current staging methods are inadequate for predicting the outcome of treatment
of non–small-cell lung cancer (NSCLC). We developed a five-gene signature that is closely …

… Importance Data sets linking comprehensive genomic profiling (CGP) to clinical outcomes
… clinical data with CGP can identify and extend associations in non–small cell lung cancer (…

… Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor
(… A weighted pooled analysis of available studies was performed to evaluate clinical outcome …

… Whether EGFR and K-RAS mutations could also predict clinical outcome of non-small cell
lung cancer (NSCLC) patients following front-line chemotherapy has not yet been established. …

… clinical outcome in patients with lung with cancer treated with ICIs. We have now examined
the possible impact of clinical … setting—including peripheral blood cell counts such as ANC, …

… the clinical outcome of treatment using real-time tumor tracking … with inoperable stage I
non-small cell lung cancer (NSCLC). … clinical results have been published for the treatment of lung …

… Adjuvant Lung Cancer Trial (IALT), the largest randomized study conducted to date of
adjuvant chemotherapy in patients with radically resected non–small cell lung carcinoma (NSCLC)…

… Multiple therapeutic options now exist for metastatic non–small-cell lung cancer (mNSCLC).
In this study we evaluated treatment patterns and outcomes in mNSCLC patients who …

OBJECTIVE: We examined the prognosis of patients with leptomeningeal metastasis (LM)
from non-small cell lung cancer (NSCLC) and that stratified by epidermal growth factor …

… patients with advanced non-small cell lung cancer, according to breast cancer resistance
protein (… B, the overall survival curves for 72 patients with advanced non-small cell lung cancer, …